Long Noncoding RNAs: Clarity or Confusion?
Because They Are Such Elusive Prey, lncRNAs Have Yet to Emerge as Therapeutic Targets
Markets Expand for Single-Use Bioreactors
Biobags Offer Advantages Over Fixed-Tank Systems
The Challenges of Harmonizing Biomarker Data
Why Trial Success Depends on It
Top 10 Wall Street Losers of 2016
These Companies Lost the Most in a Down Year for Biopharma Stocks
- STEMCELL Technologies
- 570 West Seventh Avenue
- Suite 400
- Vancouver BC, V5Z 1B3
STEMCELL Technologies is a privately-owned biotechnology company that develops specialty cell culture media, cell separation products and ancillary reagents for life science research. STEMCELL delivers over 1500 products to more than 70 countries worldwide.